SCHEMBL12769967

SCHEMBL12769967

COc1ccc(COCC[C@@H]2OC(C)(C)O[C@@H]2CO)cc1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
GBA1 P04062 1/20 0.39
UGCG Q16739 1/20 0.39
GBA2 Q9HCG7 1/20 0.39
PDE4D Q08499 3/20 0.39
CHRM3 P20309 2/20 0.38
GLA P06280 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
SLC5A1 P13866 1/20 0.38
SLC5A2 P31639 1/20 0.38
IDO1 P14902 2/20 0.37
AGXT P21549 2/20 0.37
GYPA P02724 1/20 0.37
TLR9 Q9NR96 1/20 0.36
PPARG P37231 1/20 0.35
APP P05067 4/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10565538 0.85 PDE4D (0.52) CA1GBA1UGCGGBA2PDE4D
SCHEMBL12769971 0.85 GLA (0.39) TDP1L3MBTL1CA1CA2CHRM3
SCHEMBL8076909 0.83 PDE4D (0.47) TDP1L3MBTL1CA1CA2GBA1
SCHEMBL8076913 0.83 PDE4D (0.47) TDP1L3MBTL1CA1CA2GBA1
SCHEMBL17082370 0.83 CYP3A4 (0.39) TDP1L3MBTL1CA1CA2GLA
SCHEMBL12769950 0.81 GLA (0.39) TDP1L3MBTL1CA1CA2CHRM3
SCHEMBL12769262 0.81 GLA (0.39) TDP1L3MBTL1CA1CA2CHRM3
SCHEMBL12769963 0.81 HDAC4 (0.36) TDP1L3MBTL1CHRM3GLANPSR1
SCHEMBL14212904 0.80 TDP1 (0.35) TDP1L3MBTL1CA1CA2GBA1
SCHEMBL12552190 0.77 CA1 (0.37) TDP1L3MBTL1CA1CA2PDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2308861-B1 MACROCYCLIC COMPOUNDS USEFUL AS PHARMACEUTICALS EISAI R&D MAN CO LTD (JP) 2017-03-01 EP disclosed
EP-1507773-B1 MACROCYCLIC COMPOUNDS USEFUL AS PHARMACEUTICALS EISAI R&D MAN CO LTD (JP) 2015-09-16 EP disclosed
US-7915306-B2 For therapy of inflammatory or autoimmune disorders EISAI CO., LTD. (JP) 2011-03-29 US disclosed
US-7799827-B2 Macrocyclic compounds useful as pharmaceuticals EISAI CO., LTD. (JP) 2010-09-21 US disclosed